Stock PPCB PROPANC BIOPHARMA, INC.
Add to a list
To use this feature you must be a member
Log inSign up

MarketScreener Editorial Features Propanc Biopharma, Inc.

Equities

PPCB

US74346N6022

Delayed OTC Markets
Other stock markets
 01:28:10 2024-05-09 pm EDT 		5-day change 1st Jan Change
0.0011 USD -26.67% Intraday chart for Propanc Biopharma, Inc. +37.50% -90.83%
Apr. 16 Propanc Biopharma, Inc. Receives Certificate of Grant for ?Composition of Proenzymes for Cancer Treatment? Patent from European Patent Office CI
Apr. 16 Propanc Biopharma, Inc. announced that it has received $0.025 million in funding from GS Capital Partners LLC CI

MarketScreener Editorial Features

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. PPCB Stock
  4. News Propanc Biopharma, Inc.
  5. MarketScreener Editorial Features
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW